Does Vaping Cause Lung Nodules? What the Science Says

Vaping has been linked to lung nodules in both clinical case reports and imaging studies, though the relationship is more nuanced than a simple cause-and-effect. Lung nodules are small, round spots that show up on CT scans, and they appear in vapers through at least two distinct pathways: as part of acute inflammatory lung injury and, more recently, as incidental findings in otherwise healthy young e-cigarette users. The science on long-term nodule risk is still developing, but what exists so far gives real reasons for concern.

What CT Scans Actually Show in Vapers’ Lungs

Most of the imaging data on vaping and lung abnormalities comes from the wave of severe lung injuries that swept through the United States in 2019 and 2020, known as EVALI (e-cigarette or vaping product use-associated lung injury). The dominant finding on CT scans in these patients was ground-glass opacities, a hazy cloudiness in the lung tissue visible in roughly 96% of cases in one study of 24 patients.¹ But nodules also appeared regularly. In a larger multicenter study of 160 EVALI patients, centrilobular nodules were found in about 36% of cases, alongside other common findings like septal thickening and lymphadenopathy.² Another imaging review described a CT appearance sometimes resembling hypersensitivity pneumonitis, with tiny bronchiolocentric nodular lesions reflecting the pattern of acute lung injury and organizing pneumonia seen under the microscope.³

A broader review of vaping-related lung damage described the most commonly reported imaging patterns as including bilateral ground-glass opacities in the lung bases with subpleural sparing, bilateral infiltrates, pleural effusion, and nodular opacities.⁴ So nodules are not the most common finding, but they are far from rare. They tend to show up as part of a broader inflammatory picture rather than as isolated spots.

Nodules in Young, Otherwise Healthy Vapers

The EVALI data involved people sick enough to be hospitalized, which is a specific and severe population. A newer study, VapeScan, looked at something different: lung CT findings in 18- to 49-year-old adults who were not necessarily ill. Among participants who underwent CT scanning, pulmonary nodules were the most common incidental finding, showing up in about 19% of subjects. Airway wall thickening appeared in 12%, and emphysema in 8%.⁵

Here is where it gets complicated. The VapeScan study found that the prevalence of nodules themselves did not differ significantly by vaping or smoking status. The finding that did differ was airway wall thickening: dual users of both e-cigarettes and conventional cigarettes had nearly five times the odds of airway wall thickening compared to controls, and exclusive e-cigarette users with a history of former cigarette use had about three-and-a-half times the odds.⁵ This means that while nodules were common across the study population, the structural airway changes were clearly linked to vaping behavior. It is worth noting that finding nodules in roughly one in five young adults undergoing CT is itself notable, since incidental pulmonary nodules in this age group are typically uncommon. Whether vaping played some role in those nodules even without reaching statistical significance is a question researchers are still tracking.

The Vitamin E Acetate Connection

The most dramatic lung injuries tied to vaping were traced to a specific culprit: vitamin E acetate, an oily additive used as a thickening agent in illicit THC vape cartridges. In a landmark study, vitamin E acetate was found in the lung fluid of 48 out of 51 EVALI patients sampled across 16 states, while none of the healthy comparison subjects had any trace of it. Among those patients, 94% had detectable THC or its metabolites in their lung fluid, or reported vaping THC products in the 90 days before getting sick.⁶

The problem with vitamin E acetate is straightforward: lung tissue cannot break it down or absorb it. When inhaled as an aerosol, it accumulates in the lungs and triggers intense inflammation.⁷ A mouse model of EVALI using aerosolized vitamin E acetate confirmed this mechanism, producing acute lung injuries marked by pulmonary edema, swelling of the cells lining the air sacs, and prolonged activation of immune cells called alveolar macrophages.⁸

This matters for the nodule question because the inflammatory reaction vitamin E acetate triggers is what produces many of the imaging abnormalities seen in EVALI, including those centrilobular nodules. In a clinical case report, EVALI was specifically described as a form of exogenous lipoid pneumonia or chemical irritation of the airways, occurring in an otherwise healthy patient using cannabis-containing e-cigarettes.⁹

When Nodules Disappear After Quitting

One of the more striking findings in the case report literature is that vaping-related lung nodules can resolve completely once the person stops vaping. In one published case, a patient presented with lung nodules and liver lesions so concerning that metastatic cancer was suspected. Upon cessation of e-cigarette use, the lung nodules disappeared entirely, and the liver lesions regressed.¹⁰ The title of that paper captures the clinical alarm these cases create: the imaging can look so much like cancer that patients undergo invasive workups before the true cause is identified.

A more recent case report described a patient who developed sarcoidosis, a condition featuring clusters of inflammatory cells that form nodules in the lungs and lymph nodes, apparently triggered by heavy vaping. A repeat chest CT six months after the patient quit vaping showed complete resolution of both the mediastinal lymphadenopathy and the pulmonary nodules.¹¹

These cases are encouraging in one sense: they suggest that at least some vaping-induced nodules represent reversible inflammatory reactions rather than permanent structural damage. But they also highlight a real clinical problem. Any doctor seeing unexplained lung nodules in a patient has to consider cancer, and the resulting workup can involve biopsies, PET scans, repeated imaging, and significant anxiety. If a patient does not disclose their vaping history, or if a clinician does not think to ask, the nodules may be misinterpreted.

What Happens to Lung Tissue Under the Microscope

When researchers have examined actual lung tissue from EVALI patients, the damage looks consistent regardless of the specific vaping product involved. A study of eight lung biopsies from severely ill vapers found acute lung injury across the board, including organizing pneumonia and diffuse alveolar damage. Common microscopic features included plugs of new connective tissue growing into the air sacs, a glassy coating called hyaline membranes on the alveolar walls, and overgrowth of the cells that produce surfactant.¹² A separate case series of ten biopsies confirmed the pattern, finding evidence of acute to subacute lung injury in every sample.¹³

These tissue-level findings explain why nodules appear on imaging. Organizing pneumonia, in which the body fills damaged air sacs with granulation tissue, produces the kind of small, round opacities that radiologists read as nodules on a CT scan. The centrilobular nodules described in about a third of EVALI cases on imaging correspond to these microscopic plugs of inflammatory and reparative tissue centered around the small airways.

DNA Damage and the Longer-Term Cancer Question

Inflammatory nodules that resolve after quitting are one thing. The question many people really want answered is whether vaping can cause the kind of nodules that turn out to be cancer. There is no direct clinical evidence yet that vaping causes lung cancer in humans, but the laboratory and animal data are not reassuring.

A widely cited mouse study found that e-cigarette aerosol exposure damaged DNA in lung, heart, and bladder tissue and simultaneously reduced the lung’s ability to repair that damage. The researchers found specific types of mutagenic DNA lesions and showed that the lung’s DNA-repair proteins were significantly suppressed.¹⁴ In cultured human bronchial and bladder cells, nicotine and a nicotine-derived compound enhanced both the rate of mutations and the transformation of normal cells into tumor-like cells.¹⁴ A review of the broader literature on e-cigarette vapor and cell damage confirmed that vape aerosol can produce DNA adducts, which are chemical modifications to DNA that drive oxidative stress and inflammation.¹⁵

A follow-up mouse study took things a step further. Mice exposed to e-cigarette aerosol for 54 weeks developed lung adenocarcinomas at a rate of about 23%, and bladder urothelial hyperplasia at about 58%. These lesions were extremely rare in control mice breathing filtered air or the vehicle solvent alone.¹⁶ Lung adenocarcinoma is the same cancer subtype most commonly seen in human non-smokers who develop lung cancer, which makes this particular finding hard to dismiss as irrelevant to humans.

The obvious caveat is that mice are not people, and the exposures in these studies may not mirror typical human vaping patterns. But the combination of DNA damage, impaired repair, and actual tumor formation in animals makes it biologically plausible that long-term vaping could eventually contribute to malignant nodules in humans. We just do not have the decades of epidemiological data yet to confirm or rule that out.

How Much of What You Inhale Actually Stays in Your Lungs

Part of why vaping affects the lungs at all comes down to the sheer amount of aerosol that deposits there. E-cigarette aerosol particles are small, with an average mass median diameter measured at around 410 nanometers. Depending on how someone breathes while vaping, models predict that somewhere between 15% and 45% of the inhaled aerosol mass deposits in the lungs.¹⁷ That is a substantial fraction. The aerosol is not just water vapor, despite how it looks. It carries glycerol, nicotine, flavoring compounds, and in some products, additives like vitamin E acetate. The chemical makeup shifts with particle size: lower-boiling-point components like propylene glycol tend to evaporate from smaller particles, while higher-boiling-point chemicals concentrate in the finest droplets that penetrate deepest into the airways.¹⁸

This means the smallest, most penetrating particles are actually enriched in heavier chemicals, delivering a concentrated dose to the alveoli, the tiny air sacs where gas exchange happens and where much of the inflammatory damage in EVALI patients has been found.

Dual Use Compounds the Problem

Many vapers are not exclusive e-cigarette users. A large number also smoke conventional cigarettes, and this dual use appears to carry more risk than either habit alone. A population-level analysis found that people who both vaped and smoked had higher odds of respiratory illness than those who only smoked cigarettes, with pooled odds ratios for dual use ranging from 1.20 to 1.41 across various health outcomes.¹⁹ In the VapeScan study, the strongest association with airway wall thickening was in dual users, who had nearly five times the odds compared to non-using controls.⁵

If you vape as a way to cut back on cigarettes but still smoke regularly, the evidence suggests you are not splitting the difference on risk. You may be adding to it. The lungs are dealing with two distinct sets of irritants and toxicants simultaneously, and the structural changes show up on imaging.

Flavoring Chemicals and Immune Activation in the Lungs

Beyond nicotine and carrier solvents, the flavoring chemicals in vape liquids are emerging as a concern in their own right. A recent study tested several common flavor compounds and found that cinnamaldehyde (the compound behind cinnamon flavor) and citral (a citrus flavoring) triggered maturation of dendritic cells, a type of immune cell that acts as an early alarm system in the lungs. This happened both in cell cultures and in the lungs of mice exposed to flavored vape aerosols. The vaping solvents alone did not produce the same effect, pointing to the flavorings specifically as the trigger.²⁰

Dendritic cell maturation is an early step in respiratory sensitization, the process by which the immune system becomes primed to react to an inhaled substance. Over time, repeated immune activation in the lungs could contribute to chronic inflammation, airway remodeling, and the kind of granulomatous reactions seen in the sarcoidosis case described earlier. The relevance to nodules is that granulomas and organizing inflammatory tissue are exactly what show up as nodules on a CT scan. While no one has drawn a straight line from flavored vape use to nodule formation in a large clinical study, the mechanistic pieces are falling into place.

Incidental pulmonary nodules found through CT screening are already a major source of clinical follow-up and patient anxiety even in people who have never vaped.²¹ For younger adults who vape and end up getting a chest CT for any reason, the discovery of a nodule can set off a cascade of imaging, monitoring, and sometimes invasive procedures. Knowing that vaping is a plausible explanation does not eliminate the need for follow-up, but it does change the clinical calculus. If you vape and a scan turns up lung nodules, the single most informative thing you can do is be honest with your doctor about exactly what you have been inhaling, how often, and for how long.

1
PubMed. Radiologic and Pathologic Correlation in EVALI
2
PubMed Central. CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury: A Multicenter Cohort of 160 Cases
3
PubMed Central. Pulmonary Injury Resulting from Vaping or e-Cigarette Use: Imaging Appearances at Presentation and Follow-up
4
Pneumologie. E-cigarette use-associated lung injury (EVALI)
5
American Journal of Respiratory and Critical Care Medicine. Incidental Findings on Lung CT Among 18-49 Year-old Adults Participating in the Vapescan Study of E-cigarettes
6
PubMed Central. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
7
Journal of Medical Toxicology. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury
8
PubMed Central. A mouse model of E-cigarette or vaping product use-associated lung injury (EVALI) induced by nose-only exposure to aerosolized vitamin E acetate and associated macrophage dysfunction
9
PubMed Central. Vaping-Induced Lung Injury: A Case of Lipoid Pneumonia Associated with E-Cigarettes Containing Cannabis
10
PubMed. A Cancer That Went Up in Smoke: Pulmonary Reaction to e-Cigarettes Imitating Metastatic Cancer
11
American Journal of Respiratory and Critical Care Medicine. Vaping-Associated Sarcoidosis: A Case Report of Recovery Following Cessation
12
American Journal of Clinical Pathology. Lung Biopsy Findings in Severe Pulmonary Illness Associated With E-Cigarette Use (Vaping): A Report of Eight Cases
13
PubMed Central. Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series
14
PubMed Central. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells
15
PubMed Central. Mechanisms of E-Cigarette Vape-Induced Epithelial Cell Damage
16
Proceedings of the National Academy of Sciences. Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice
17
PubMed. Predicted Deposition of E-Cigarette Aerosol in the Human Lungs
18
PubMed Central. Estimation of the Dose of Electronic Cigarette Chemicals Deposited in Human Airways through Passive Vaping
19
PubMed Central. Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes
20
American Journal of Physiology-Lung Cellular and Molecular Physiology. Flavor chemicals in vaping products induce pulmonary dendritic cell maturation
21
PubMed Central. Diagnostic approach for incidental pulmonary nodules